264 related articles for article (PubMed ID: 38383747)
21. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
[TBL] [Abstract][Full Text] [Related]
22. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
23. CD45RO
Zhou WJ; Zhang J; Xie F; Wu JN; Ye JF; Wang J; Wu K; Li MQ
Theranostics; 2021; 11(11):5330-5345. PubMed ID: 33859750
[No Abstract] [Full Text] [Related]
24. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract][Full Text] [Related]
25. Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.
Meng T; Wang Q; Yang Y; Ren Y; Shi Y
Front Genet; 2022; 13():825261. PubMed ID: 35495130
[No Abstract] [Full Text] [Related]
26. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
27. A Five-microRNA Signature as Risk Stratification System in Uterine Corpus Endometrial Carcinoma.
Chen Z; Huang X; Lv Y; Fang Y; Pan L; Gan Z; Huang Z; Wei W
Comb Chem High Throughput Screen; 2021; 24(2):187-194. PubMed ID: 32748742
[TBL] [Abstract][Full Text] [Related]
28. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.
Zhang X; Ye Z; Xiao G; He T
Comput Biol Med; 2023 Jun; 159():106905. PubMed ID: 37060773
[TBL] [Abstract][Full Text] [Related]
29. Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis.
Yao Y; Shi L; Zhu X
Medicine (Baltimore); 2023 Aug; 102(34):e34998. PubMed ID: 37653757
[TBL] [Abstract][Full Text] [Related]
30. Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma.
Zhao L; Fu X; Han X; Yu Y; Ye Y; Gao J
Cancer Cell Int; 2021 Jan; 21(1):80. PubMed ID: 33509222
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma.
Wang M; Yue S; Yang Z
Sci Rep; 2023 Mar; 13(1):4081. PubMed ID: 36906716
[TBL] [Abstract][Full Text] [Related]
32. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.
Zou R; Liu Y; Qiu S; Lu Y; Chen Y; Yu H; Zhu H; Zhu W; Zhu L; Feng J; Han J
Cancer Biomark; 2023; 38(4):551-566. PubMed ID: 38007640
[TBL] [Abstract][Full Text] [Related]
33. miRNA profiling of human nasopharyngeal carcinoma cell lines HONE1 and CNE2 after X-ray therapy.
Luo H; Zhong F; Jing X; Lin H; Li Y
Adv Clin Exp Med; 2022 Jun; 31(6):671-687. PubMed ID: 35275451
[TBL] [Abstract][Full Text] [Related]
34. miRNA-seq analysis of human vertebrae provides insight into the mechanism underlying GIOP.
Ren H; Yu X; Shen G; Zhang Z; Shang Q; Zhao W; Huang J; Yu P; Zhan M; Lu Y; Liang Z; Tang J; Liang D; Yao Z; Yang Z; Jiang X
Bone; 2019 Mar; 120():371-386. PubMed ID: 30503955
[TBL] [Abstract][Full Text] [Related]
35. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
36. Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors.
Gao T; Zhao L; Zhang F; Cao C; Fan S; Shi X
World J Surg Oncol; 2022 Jun; 20(1):207. PubMed ID: 35710427
[TBL] [Abstract][Full Text] [Related]
37. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
Li J; Gu X; Gao C; Zhang J
Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
[TBL] [Abstract][Full Text] [Related]
38. Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer.
Lin Z; Fan W; Sui X; Wang J; Zhao J
Reprod Sci; 2023 Feb; 30(2):576-589. PubMed ID: 35854199
[TBL] [Abstract][Full Text] [Related]
39. Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinoma.
Xiong H; Li Q; Liu S; Wang F; Xiong Z; Chen J; Chen H; Yang Y; Tan X; Luo Q; Peng J; Xiao G; Jiang Q
PLoS One; 2014; 9(10):e110163. PubMed ID: 25329664
[TBL] [Abstract][Full Text] [Related]
40. Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma.
Yerukala Sathipati S; Aimalla N; Tsai MJ; Carter T; Jeong S; Wen Z; Shukla SK; Sharma R; Ho SY
Carcinogenesis; 2023 Dec; 44(8-9):650-661. PubMed ID: 37701974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]